IDStewardship

OCTOBER 14, 2024

In this article an infectious diseases pharmacist discusses something cool and something lame with 5 antibiotics. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted October 2024, First Released in the August 2024 IDstewardship Newsletter 1. Ciprofloxacin Something cool: It can be given orally to treat a variety of different Pseudomonas aeruginosa infections – yay for avoiding intravenous catheters!

130

130

Drug Topics

OCTOBER 14, 2024

Erin Albert, vice president of pharmacy relations and chief privacy officer at Mark Cuban Cost Plus Drug Company, PBC, discussed drug pricing and what her company is doing to revolutionize transparency.

123

123

IDStewardship

OCTOBER 14, 2024

In this article an infectious diseases pharmacist with 20+ years of experience in the profession discusses 5 quick things to know about drug shortages. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted October 2024, First Released in the July 2024 IDstewardship Newsletter 1. Not all drug “shortages” are created equal When someone says there is a “shortage” of drug, that can mean a lot of different things.

Communication 130

Communication 130

Pharmacy Times

OCTOBER 14, 2024

The lawsuit alleges that the action was taken without the required notice and disputes the agency’s warning of “localized supply disruption,” while calling for more transparency.

FDA 132

FDA 132

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

IDStewardship

OCTOBER 14, 2024

In this article an infectious diseases pharmacist discusses 5 neat things from the world of antimicrobials – let’s get nerdy! Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted October 2024, First Released in the September 2024 IDstewardship Newsletter 1. Echinocandins are associated with a paradoxical effect Giving more drug leads to less fungal killing?

130

130

Drug Topics

OCTOBER 14, 2024

Research presented at ACCP 2024 found that addiction medicine consult services could help increase medication for opioid use disorder initiation.

123

123

Drug Topics

OCTOBER 14, 2024

As health care systems and the current syndemic continue to evolve, pharmacies are poised to play a crucial role in improving public health.

123

123

Pharmacy Times

OCTOBER 14, 2024

Behind The Script is a photo submission campaign designed to feature real pharmacists with candid, HIPPA-compliant photos to celebrate American Pharmacist Month.

65

65

Drug Topics

OCTOBER 14, 2024

Jon Minkin, enterprise account executive at NimbleRx, shared how his company can help independent pharmacies unlock revenue opportunities.

Independent Pharmacies 123

Independent Pharmacies 123

Pharmacy Times

OCTOBER 14, 2024

In this interview for World Standards Week, Nakia Eldridge, PharmD, MPH, of US Pharmacopeia (USP), discusses USP's key achievements in 2024, while outlining the organization's 2025 goals.

65

65

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

OCTOBER 14, 2024

Biotech investors have been buzzing around new areas of drug development this year, such as the red-hot obesity market. But there’s one field that has seen an even more significant amount of activity: autoimmune diseases. Companies that are developing new medicines for autoimmune conditions, as well as other immune system disorders, have brought in more money and closed more deals so far this year than most other areas, including the cardiometabolic field, data from investment bank Oppenh

Immunization 129

Immunization 129

Pharmacy Times

OCTOBER 14, 2024

Artificial Intelligence (AI) is transforming drug development by automating routine tasks, enhancing clinical trials, and expediting drug discovery, ultimately leading to more personalized treatments.

111

111

Drug Topics

OCTOBER 14, 2024

Researchers addressed the prevalence of RSV and its associations with immunization, infection, and hospitalization amongst older adults.

Hospitals 98

Hospitals Immunization Vaccines 98

STAT

OCTOBER 14, 2024

LONDON — The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals, which is developing treatments for neurological diseases, in a deal worth $2.6 billion.  As part of the deal, which is expected to close in the fourth quarter, Lundbeck is paying $60 per share in cash for Longboard, a 54% premium on Friday’s closing price of $38.90.

101

101

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

OCTOBER 14, 2024

Damage to a Baxter manufacturing facility caused by Hurricane Helene, which rolled across the east US a couple of weeks ago, has led to shortages in some critical medicines.The plant in North Cove, North Carolina, was severely affected by flooding and had to be shut down at the end of September. It is Baxter's biggest manufacturing site and is also the largest supplier of intravenous and peritoneal dialysis solutions to the US market.

103

103

STAT

OCTOBER 14, 2024

The  Broad Institute of MIT and Harvard , one of the most prominent biotech research centers in the world, has laid off 87 employees, a spokesperson confirmed. The layoffs came as a lucrative partnership with Microsoft was expected to conclude at the end of the year. In an email to staff Thursday, Todd Golub, the Broad’s director, attributed the cuts to the “rapid pace of technological and scientific change [which] requires us to retool to stay ahead” in the institute&#

100

100

pharmaphorum

OCTOBER 14, 2024

GSK's six-monthly IL-5 inhibitor depemokimab clears two phase 3 trials in chronic rhinosinusitis with nasal polyps (CRSwNP), its second indication

98

98

STAT

OCTOBER 14, 2024

When the U.S. health care system pivoted to meet Covid-19 in 2020, routine health visits and screenings where many cancer cases would have been caught didn’t happen. It wasn’t ideal, but many health experts thought that as the country opened back up, screenings would help “catch up” to these missed cases. A new paper published Monday in JAMA Network Open suggests that didn’t happen as quickly as experts had hoped.

100

100

Fierce Pharma

OCTOBER 14, 2024

Four days after a compounding industry group filed a lawsuit against the FDA | Four days after a compounding industry group filed a lawsuit against the FDA for removing Eli Lilly’s tirzepatide products from its shortage list, the U.S. regulator is taking a second look at its decision.

Compounding 90

Compounding FDA 90

STAT

OCTOBER 14, 2024

Jasper Therapeutics, a biotech looking to make stem cell transplants less taxing and to treat immune-mediated diseases, reported on Monday that its experimental drug helped patients with a chronic skin condition in an initial and closely watched clinical trial. In the Phase 1/2 study, dubbed Spotlight, 14 of 15 patients given an injection of the drug, briquilimab, showed improvements in symptoms of chronic inducible urticaria, a disease defined by red, itchy welts.

Immunization 97

Immunization 97

Drug Topics

OCTOBER 14, 2024

The FDA approved ceftobiprole medocaril sodium for injection (Zevtera) in April 2024.

FDA 98

FDA 98

pharmaphorum

OCTOBER 14, 2024

Eli Lilly may invest $364m in the UK and work with the government to tackle serious public health challenges including obesity.

98

98

Pharmacy Times

OCTOBER 14, 2024

Offering pharmacy professionals insights into the benefits, importance and challenges associated with switching patients to long-acting injectables to treat schizophrenia.

73

73

STAT

OCTOBER 14, 2024

A transplant to Boston from Brazil, my patient worked as a hairdresser but had developed painful rashes on her hands that peeled and cracked, making it impossible to do her job. I diagnosed her with an allergy to para-phenylenediamine, an ingredient in certain styling products she used at the salon. Her skin recovered as she avoided this chemical. A careful medical evaluation had healed her hands and allowed her to maintain her livelihood, her self-sufficiency, and the social connections with co

97

97

Fierce Pharma

OCTOBER 14, 2024

On a mission to collect a key Crohn’s disease approval and build out its inflammatory bowel disease (IBD) profile, Eli Lilly has notched a trial win over a major rival in a head-to-head study.&nbsp | Eli Lilly's drug outperformed Johnson & Johnson's established Stelara in a phase 3 study that looked at histologic disease responses over 52 weeks.

78

78

Pharmacy Times

OCTOBER 14, 2024

Criticism and inquiry are coming from all directions. Will investors earn more by holding on to the past or transitioning toward the future?

65

65

Fierce Pharma

OCTOBER 14, 2024

Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena plots its U.S. debut. | Catalent is selling its oral solids facility in Somerset, New Jersey, to Belgium’s Ardena for an undisclosed sum. The site also doubles as Catalent's current corporate headquarters.

65

65

Pharmacy Times

OCTOBER 14, 2024

Ilianette Miranda, RPh discusses her career-long efforts to integrate pharmacists into the health care system in Puerto Rico.

81

81

Fierce Healthcare

OCTOBER 14, 2024

The former CEO of a Chicago safety-net hospital has been charged for his alleged role in a multimillion-dollar embezzlement scheme, for which two other hospital leaders and the owner of medical sup | George Miller, formerly CEO of Loretto Hospital in Chicago, allegedly helped direct at least $19 million of hospital funds to certain medical supply companies "in exchange for cash.

Hospitals 69

Hospitals 69

Pharmacy Times

OCTOBER 14, 2024

Employers can support technicians by investing in certification opportunities.

94

94

STAT

OCTOBER 14, 2024

When children’s hospitals around the country were subject to threats and harassment in 2022 over misconceptions about gender-affirming care services, many of them responded by stripping information about the care from their websites. Two years later, new research shows that few adult and children’s hospital websites share information about LGBTQ+ services and policies.

Hospitals 66

Hospitals Medical Schools 66

Pharmacy Times

OCTOBER 14, 2024

Pharmacists and the pharmacies they support are in a strong position to increase vaccination rates and address any questions related to vaccine hesitancy.

Vaccines 65

Vaccines 65

Fierce Pharma

OCTOBER 14, 2024

The FDA’s rejection of Vanda Pharmaceuticals’ stomach disease candidate has done little to dampen the enthusiasm of England’s Cycle Pharmaceuticals to acquire the Washington D.C.-based company. | The FDA’s rejection of Vanda Pharmaceuticals’ stomach disease candidate has done little to dampen the enthusiasm of England’s Cycle Pharmaceuticals to acquire the Washington, D.C.

FDA 65

FDA 65

Pharmacy Times

OCTOBER 14, 2024

The president and CEO of Employer’s Forum of Indiana says the pharmacists must be involved and engaged with employers to improve outcomes in health care.

65

65